Details of Disease

General Information of Disease (ID: DIS1SW33)

• Disease Name: Dermatomycosis
• Disease Class: EA60: Skin fungal infection disorder
• Definition: Superficial infections of the skin or its appendages by any of various fungi.
• Disease Hierarchy:
  DIS1MY8X: Cutaneous mycosis
  DIS1SW33: Dermatomycosis
• ICD Code: ICD-11: ICD-11: EA60
• Disease Identifiers:
  MONDO ID: MONDO_0002040
  MESH ID: D003881
  UMLS CUI: C0011630
  MedGen ID: 8330
  SNOMED CT ID: 14560005

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 2 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Coccidioidin	DMMOGJ0	Approved	NA	[1]
Naftifine	DMHVBG1	Approved	Small molecular drug	[2]

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
PF-06823859	DM8C1H4	Phase 2	NA	[3]

This Disease is Treated as An Indication in 1 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
CP-640922	DMX793V	Discontinued in Phase 2	NA	[4]

This Disease is Treated as An Indication in 1 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
AgaDerm	DM144PL	Investigative	NA	[5]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [2] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 019356.
• [3] ClinicalTrials.gov (NCT03181893) A Study In Adults With Moderate To Severe Dermatomyositis. U.S. National Institutes of Health.
• [4] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025648)
• [5] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.